We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

ABI-007 With Carboplatin as First-Line Therapy in Patients With Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Carcinoma

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00407407
Recruitment Status : Terminated (MTD not determined)
First Posted : December 5, 2006
Last Update Posted : April 9, 2012
Information provided by (Responsible Party):
Celgene ( Celgene Corporation )

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Terminated
  Primary Completion Date : February 2008
  Study Completion Date : February 2008